Novanta (NASDAQ:NOVT) Stock Price Down 8.8% – Here’s Why

Posted by Brenda Bartman on Jul 7th, 2026

Shares of Novanta Inc. (NASDAQ:NOVT – Get Free Report) fell 8.8% during trading on Tuesday . The company traded as low as $153.83 and last traded at $150.4350. Approximately 49,353 shares were traded during mid-day trading, a decline of 89% from the average session volume of 464,784 shares. The stock had previously closed at $164.89.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on NOVT shares. Weiss Ratings reissued a “hold (c-)” rating on shares of Novanta in a research report on Friday, April 17th. Wall Street Zen upgraded Novanta from a “hold” rating to a “buy” rating in a research note on Saturday, June 27th. Finally, Robert W. Baird set a $180.00 price target on Novanta in a report on Tuesday, June 9th. One equities research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Novanta presently has an average rating of “Hold” and an average price target of $180.00.

Read Our Latest Research Report on NOVT

Novanta Trading Down 10.4%

The firm has a market cap of $5.58 billion, a P/E ratio of 107.18 and a beta of 1.67. The business’s 50 day moving average is $153.42 and its 200-day moving average is $137.55. The company has a quick ratio of 2.69, a current ratio of 3.56 and a debt-to-equity ratio of 0.15.

Novanta (NASDAQ:NOVT – Get Free Report) last announced its quarterly earnings data on Monday, May 11th. The technology company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.78 by $0.03. The company had revenue of $257.71 million during the quarter, compared to analyst estimates of $253.40 million. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same period last year, the business earned $0.74 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. As a group, analysts forecast that Novanta Inc. will post 3.59 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CEO Matthijs Glastra sold 7,500 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $150.43, for a total value of $1,128,225.00. Following the completion of the sale, the chief executive officer directly owned 42,761 shares of the company’s stock, valued at $6,432,537.23. The trade was a 14.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.20% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in NOVT. Allworth Financial LP lifted its position in shares of Novanta by 978.4% in the 4th quarter. Allworth Financial LP now owns 399 shares of the technology company’s stock worth $47,000 after buying an additional 362 shares during the last quarter. Danske Bank A S bought a new stake in shares of Novanta during the 3rd quarter valued at about $40,000. EverSource Wealth Advisors LLC grew its position in shares of Novanta by 120.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock valued at $51,000 after buying an additional 233 shares during the last quarter. ANTIPODES PARTNERS Ltd acquired a new stake in Novanta during the fourth quarter worth about $53,000. Finally, Farther Finance Advisors LLC raised its stake in Novanta by 1,291.4% during the fourth quarter. Farther Finance Advisors LLC now owns 487 shares of the technology company’s stock worth $58,000 after acquiring an additional 452 shares during the period. Institutional investors and hedge funds own 98.35% of the company’s stock.

Novanta Company Profile

(Get Free Report)

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.